D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6) taraf\u0131ndan belirlenen 28 Temmuz D\u00fcnya Hepatit G\u00fcn\u00fc\u2019ne \u00f6zel a\u00e7\u0131klamalarda bulunan Medicana Sa\u011fl\u0131k Grubu Enfeksiyon Hastal\u0131klar\u0131 B\u00f6l\u00fcm\u00fc\u2019nden Prof. Dr. Serhan Sakarya, hepatit hastal\u0131\u011f\u0131n\u0131n iyi tan\u0131nmas\u0131 gerekti\u011finin mesaj\u0131n\u0131 verdi. Hepatit konusunda en b\u00fcy\u00fck sorunun kan yoluyla ve cinsel yolla olan bula\u015f oldu\u011funu s\u00f6yleyen Prof. Dr. Serhan Sakarya “T\u00fcrkiye\u2019de her 100 ki\u015fiden 24\u2019\u00fcnde hepatit g\u00f6r\u00fcl\u00fcyor” dedi.
\n
D\u00fcnya Hepatit G\u00fcn\u00fc dolay\u0131s\u0131yla hepatit hastal\u0131\u011f\u0131 hakk\u0131nda a\u00e7\u0131klamalarda bulunan Medicana International \u0130zmir Hastanesi Enfeksiyon Hastal\u0131klar\u0131 Uzman\u0131 Prof. Dr. Serhan Sakarya, hepatit hastal\u0131\u011f\u0131n\u0131 iyi tan\u0131mak gerekti\u011finin alt\u0131n\u0131 \u00e7izdi. Prof. Dr. Serhan Sakarya, “Hepatit, karaci\u011fer h\u00fccrelerinin hasarlanmas\u0131na ba\u011fl\u0131 geli\u015fmi\u015f olan klinik bir tablo olarak \u00f6zetlenebilir. Bu tablo bir\u00e7ok nedene ba\u011fl\u0131 olarak geli\u015febilir. Enfeksiyon hastal\u0131klar\u0131 ba\u015fta olmak \u00fczere otoimm\u00fcn hastal\u0131klar, yedi\u011fimiz i\u00e7ti\u011fimiz g\u0131dalara ba\u011fl\u0131 olarak geli\u015fen hepatitler ya da ilaca ba\u011fl\u0131 toksin olarak geli\u015fen hepatitler bunlar\u0131n hepsi hepatit olarak tan\u0131mlan\u0131r. Ama toplum i\u00e7inde akla gelen en \u00f6nemli \u015fey mikroplarla olan hepatitlerdir. Bu nedenle hepatitleri iyi tan\u0131mlamak gerekiyor” dedi.<\/p>\n
T\u0131pk\u0131 grip gibi bula\u015fabiliyor
\n
Hepatitlerin bula\u015fma \u015fekli hakk\u0131nda bilgi veren Prof. Dr. Serhan Sakarya, “Bula\u015f\u0131c\u0131 hepatitler t\u0131pk\u0131 grip, nezle, zat\u00fcrre gibi bula\u015f\u0131r. Hepatit vir\u00fcs\u00fc denilen A, B, C, D ve E\u2019den olu\u015fan vir\u00fcsler ve bunun yan\u0131nda baz\u0131 di\u011fer vir\u00fcsler \u00f6rne\u011fin; Epstein-Barr, Sitomegalovir\u00fcs (CMV), brusella, t\u00fcberk\u00fcloz gibi mikroplar karaci\u011feri tutaraktan hepatit yapabilir. Fakat bizim \u00e7o\u011funlukla enfeksiyon olarak viral hepatitler dedi\u011fimiz bu sayd\u0131\u011f\u0131m A, B, C, D ve E\u2019lerdir. Bunlar\u0131n baz\u0131lar\u0131 a\u011f\u0131z yoluyla bula\u015f\u0131r. Yani g\u0131dalar yoluyla bula\u015f\u0131r, baz\u0131lar\u0131 da kan yoluyla bula\u015f\u0131r. \u00d6zellikle A ve E, g\u0131da ve suyla bula\u015fan hepatit t\u00fcr\u00fc olup, salg\u0131n yoluyla seyredebilir. Bunlar genellikle ya\u015fa ve ba\u011f\u0131\u015f\u0131k yan\u0131ta ba\u011fl\u0131 olarak farkl\u0131 klinik \u015fekilde seyredebilir. \u00c7ocuklarda genellikle hafif seyrederken, b\u00fcy\u00fcklerde a\u011f\u0131r seyreder. \u00c7\u00fcnk\u00fc b\u00fcy\u00fcklerde ba\u011f\u0131\u015f\u0131k yan\u0131t daha g\u00fc\u00e7l\u00fc oldu\u011fu i\u00e7in hastal\u0131\u011fa kar\u015f\u0131 daha g\u00fc\u00e7l\u00fc cevap vermekte ve bu cevap da karaci\u011feri y\u0131kmaktad\u0131r. Ba\u011f\u0131\u015f\u0131kl\u0131k ne kadar g\u00fc\u00e7l\u00fcyse o kadar \u00e7ok karaci\u011ferde tahribat olu\u015fuyor. A\u011f\u0131z yoluyla bula\u015fan hepatitlerde klinik de\u011fi\u015fken olmakla birlikte y\u00fcz g\u00fcld\u00fcr\u00fcc\u00fcd\u00fcr \u00e7\u00fcnk\u00fc kronikle\u015fme riski yoktur. Hepatitlerde en \u00e7ok korkulan, kronik karaci\u011fer hastal\u0131\u011f\u0131 olan siroz ya da kanserdir. Onun i\u00e7in bu sayd\u0131klar\u0131m\u0131zda bu risk yoktur. Ama Hepatit B de ve Hepatit C de bu riskler \u00e7ok y\u00fcksektir. B ve C kendi ba\u015f\u0131na birer vir\u00fcsken D ise inkoplekt tam vir\u00fcs olmayan bir bula\u015fand\u0131r” a\u00e7\u0131klamas\u0131n\u0131 yapt\u0131. Prof. Dr. Serhan Sakarya, hepatitler konusunda en b\u00fcy\u00fck sorunun kan ve cinsel yolla olan bula\u015f oldu\u011funu vurgulad\u0131.
\n
Hepatit C i\u00e7in bir a\u015f\u0131 olmad\u0131\u011f\u0131n\u0131 ve bu vir\u00fcs\u00fcn kan yoluyla bula\u015ft\u0131\u011f\u0131n\u0131 ifade eden Prof. Dr. Serhan Sakarya, “Hepatit C\u2019ye kar\u015f\u0131 a\u015f\u0131 yoktur. Kan yoluyla bula\u015f\u0131r ve de siroz ve kanser yapma riski y\u00fcksektir. Fakat yeni \u00e7\u0131kan antiviraller y\u00fczde 100 tedavi edebilme \u00f6zelli\u011fine sahiptir. Ama B i\u00e7in hasta oldu\u011funuz takdirde yap\u0131lacak olan tedavi ile tamamen vir\u00fcsten kurtulma \u015fans\u0131n\u0131z y\u00fczde 8 ile 12 aras\u0131ndad\u0131r. Onun i\u00e7in \u00f6m\u00fcr boyu tedavi olma ihtiyac\u0131 ortaya \u00e7\u0131kabilir” diye konu\u015ftu.<\/p>\n
A\u015f\u0131lanma hastal\u0131k oran\u0131n\u0131 ciddi oranda d\u00fc\u015f\u00fcr\u00fcyor
\n
Hepatite kar\u015f\u0131 korunman\u0131n yollar\u0131na dikkat \u00e7eken Prof. Dr. Serhan Sakarya, \u00f6zellikle Hepatit B\u2019ye kar\u015f\u0131 geli\u015ftirilen a\u015f\u0131y\u0131 hat\u0131rlatarak, “Hepatit B\u2019ye kar\u015f\u0131 yap\u0131lan a\u015f\u0131lar; Hepatit B\u2019ye ve dolay\u0131s\u0131yla Hepatit D\u2019ye kar\u015f\u0131 koruma sa\u011fl\u0131yor. Bu a\u015f\u0131lar \u00e7ocukluk d\u00f6neminde yap\u0131lmas\u0131 gereken a\u015f\u0131lard\u0131r. T\u00fcrkiye\u2019de de yap\u0131lan \u00e7al\u0131\u015fmalar g\u00f6stermi\u015ftir ki a\u015f\u0131lanma hastal\u0131k oran\u0131n\u0131 ciddi oranda d\u00fc\u015f\u00fcrm\u00fc\u015ft\u00fcr. Buna farkl\u0131 bir g\u00f6zle bakarsak, bir kronik karaci\u011fer hastas\u0131n\u0131n tedavi maliyeti yakla\u015f\u0131k olarak 10 binlerce insan\u0131n a\u015f\u0131lanmas\u0131 maliyeti kadard\u0131r. Dolay\u0131s\u0131yla a\u015f\u0131lanma bu anlamda \u00e7ok \u00f6nemli. \u00d6zellikle sa\u011fl\u0131k \u00e7al\u0131\u015fanlar\u0131 ve geli\u015fen nesil i\u00e7in tamamen temiz bir \u00fclke ve \u00e7evre yarat\u0131labilir. Bunun en g\u00fczel \u00f6rne\u011fi K\u00fcba\u2019d\u0131r. A\u015f\u0131lanma sayesinde 2012 y\u0131l\u0131ndan beri hi\u00e7 vaka g\u00f6r\u00fclmeyen \u00fclke haline gelmi\u015ftir” mesaj\u0131n\u0131 verdi.<\/p>\n
Tedavi gecikirse sonu\u00e7 organ yetmezli\u011fine varabilir
\n
T\u00fcrkiye\u2019de her 100 ki\u015fiden 24\u2019\u00fcnde Hepatit B g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc aktaran Prof. Dr. Serhan Sakarya, hepatit hastal\u0131\u011f\u0131n\u0131n belirtileri hakk\u0131nda bilgi verdi. Hastal\u0131\u011f\u0131n akut ve kronik d\u00f6nemleri oldu\u011funu ayr\u0131ca sessiz ta\u015f\u0131y\u0131c\u0131 diye konu\u015fulan bir d\u00f6nemi de oldu\u011funu belirten Prof. Dr. Serhan Sakarya, “Akut d\u00f6nem ayn\u0131 enfeksiyonlar gibi ba\u015flar. Ate\u015f kusma bulant\u0131 i\u015ftahs\u0131zl\u0131k gibi… Hemen arkas\u0131ndan geli\u015fen bir sar\u0131l\u0131k hali olur. \u0130drar renginde koyula\u015fma, ciltte ve g\u00f6zlerde sararmalarla hasta bunu anlar. Hepatitin de her enfeksiyon gibi ba\u015flang\u0131c\u0131 benzerdir. Hastal\u0131\u011f\u0131n alevlenme d\u00f6neminde karaci\u011ferdeki y\u0131k\u0131m enzimleri \u00e7ok artar. Cilt tamamen sarar\u0131r, idrar rengi koyula\u015f\u0131r, d\u0131\u015fk\u0131 rengi a\u00e7\u0131l\u0131r. Hastada bu d\u00f6nemde bile \u00e7ok ciddi bulgular olmaz. Halsizlik d\u0131\u015f\u0131nda bazen hafif bulant\u0131 g\u00f6r\u00fclebilir. Hasta aksine kendini iyi hisseder. Bu \u00e7ok s\u0131k\u0131nt\u0131l\u0131 bir tablodur. \u00c7\u00fcnk\u00fc iyi hissetti\u011fi i\u00e7in tedavi ad\u0131na gerekli olan istirahat ve kendine vermesi gereken \u00f6nemi g\u00f6stermez. Bu da \u00e7ok h\u0131zl\u0131 bir \u015fekilde alevli ve h\u0131zla ilerleyip hastan\u0131n \u00f6l\u00fcm\u00fcyle sonu\u00e7lanabilen ve karaci\u011feri hemen hemen hepsinin yok oldu\u011fu organ yetmezli\u011fine varabilir. Ya da kronik fazda kalabilir. Kronik faz\u0131n sonunda siroz ya da kanser olarak devam edebilir” ifadelerini kaydetti.
\n
\u00d6te yandan Prof. Dr. Serhan Sakarya, hepatitin belirtilerinin hastay\u0131 yan\u0131ltmas\u0131ndan kaynakl\u0131 bula\u015f oldu\u011funda pek anla\u015f\u0131lamad\u0131\u011f\u0131n\u0131 belirterek, genellikle hastalar\u0131n ameliyat \u00f6ncesinde ya da check-up s\u0131ras\u0131nda yap\u0131lan testlerle hepatit oldu\u011funu \u00f6\u011frenebildi\u011fini s\u00f6yledi.
<\/p>\n","protected":false},"excerpt":{"rendered":"
D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc (DS\u00d6) taraf\u0131ndan belirlenen 28 Temmuz D\u00fcnya Hepatit G\u00fcn\u00fc\u2019ne \u00f6zel a\u00e7\u0131klamalarda bulunan Medicana Sa\u011fl\u0131k Grubu Enfeksiyon Hastal\u0131klar\u0131 B\u00f6l\u00fcm\u00fc\u2019nden Prof. Dr. Serhan Sakarya, hepatit hastal\u0131\u011f\u0131n\u0131n iyi tan\u0131nmas\u0131 gerekti\u011finin mesaj\u0131n\u0131 verdi. Hepatit konusunda en b\u00fcy\u00fck sorunun kan yoluyla ve cinsel yolla olan bula\u015f oldu\u011funu s\u00f6yleyen Prof. Dr. Serhan Sakarya “T\u00fcrkiye\u2019de her 100 ki\u015fiden 24\u2019\u00fcnde hepatit…<\/p>\n","protected":false},"author":1,"featured_media":45088,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[2],"tags":[],"class_list":["post-45087","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik"],"_links":{"self":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/45087","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=45087"}],"version-history":[{"count":1,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/45087\/revisions"}],"predecessor-version":[{"id":45089,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/posts\/45087\/revisions\/45089"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=\/wp\/v2\/media\/45088"}],"wp:attachment":[{"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=45087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=45087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.egemtv.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=45087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}